SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

Thursday 15th October 2020

National Institutes of Health COVID-19 Interest Group Seminar Series

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

Kizzmekia Corbett, Ph.D., NIH NIAID

to be available at videocast.nih.gov

 


Event Details


Upcoming Events

slide 18 to 20 of 9

11th International gamma/delta T Cell Conference

Tuesday 20th May 2025 at Hilton Toronto DowntownCanadian Society for Immunology

Zooming into the Adaptive Immune Receptor Repertoire (AIRR) Community III

Wednesday 21st May 2025Nomenclature Committee (NOM)

45th Congress of the Spanish Society of Immunology, Santander, Spain

Thursday 22nd May 2025 at plaza de las estacionesSociedad Española de Inmunologia